Stocks in the NewsMost Active StocksPercent GainersPercent LosersFollowed Stocks
,

Latest News

Rocket Lab Hit 100 Launches Faster Than Any Other Commercially Developed Rocket. I'd Buy a Small Stake.fool.com
The small rocket has proven it can fly often. Does that tell investors anything about the big one?
Via The Motley Fool · November 16, 2026
United Therapeutics Prepares for TYVASO Expansion After $833 Million Quartermarketbeat.com
United Therapeutics (NASDAQ:UTHR) is preparing for a potential expansion of its TYVASO franchise into idiopathic pulmonary fibrosis, while its executives pointed to strong third-quarter sales and a pipeline of regulatory and clinical milestones at the UBS London Healthcare Conference. The company r
Via MarketBeat · November 16, 2026
Agora Q3 Earnings Call Highlightsmarketbeat.com
Agora (NASDAQ:API) reported third-quarter 2026 revenue of $42.1 million, up 19% from a year earlier, as growth in its real-time engagement business and increasing contributions from conversational artificial intelligence products helped drive a third consecutive quarter of accelerating revenue growt
Via MarketBeat · November 16, 2026
Yalla Group Q3 Earnings Call Highlightsmarketbeat.com
Yalla Group (NYSE:YALA) reported a modest increase in third-quarter revenue as new games began contributing to sales, but higher marketing and development expenses weighed on earnings. Management said it expects the gaming business to drive double-digit revenue growth in 2027 while warning that prof
Via MarketBeat · November 16, 2026
How Much to Invest in TC Energy for $142 a Quarter in Dividendsfool.ca
With predictable cash flows, consistent dividend growth, an attractive yield, and clear growth opportunities, TC Energy is ideal for income-seeking investors.
Via The Motley Fool · November 16, 2026
If a Bear Market Is Coming, History Says This Is the Safest Investing Move You Can Makefool.com
Bear markets are a normal part of investing; your safest path through a downturn is sticking to your long-term plan.
Via The Motley Fool · November 16, 2026
Where Could Celestica Stock Be in 5 Years? What the New Outlook Meansfool.ca
Celestica’s ambitious 2027 outlook and accelerating AI infrastructure demand could fuel its next phase of growth, making its recent stock price weakness worth a closer look.
Via The Motley Fool · November 16, 2026
1 Number Reveals Which Is the Better Buy Between Nvidia and AMDfool.com
Is AMD really worth three times as much as Nvidia?
Via The Motley Fool · November 16, 2026
How Much Would You Need in SmartCentres to Collect $250 a Month?fool.ca
SmartCentres can pay an actual monthly distribution. Reaching $250 from it alone would require nearly $45,000 at recent prices.
Via The Motley Fool · November 16, 2026
Standard Lithium Q3 Earnings Call Highlightsmarketbeat.com
Standard Lithium (NYSEAMERICAN:SLI) expects to make a final investment decision on its South West Arkansas lithium project by the end of the first quarter of 2027, a timeline that means the company expects to forgo a $40 million payment from joint venture partner Equinor. CEO David Park said the co
Via MarketBeat · November 16, 2026
Intermap Technologies Q3 Earnings Call Highlightsmarketbeat.com
Intermap Technologies (TSE:IMP) reported higher third-quarter revenue but a wider loss as delays in an Indonesian mapping procurement and costs associated with its acquisition of PCI Geomatics weighed on results. Revenue rose 5% to $1.8 million, while the net loss widened to $4 million, or $0.05 pe
Via MarketBeat · November 16, 2026
K92 Mining Q3 Earnings Call Highlightsmarketbeat.com
K92 Mining (TSE:KNT) reported its second-highest quarterly production on record in the third quarter of 2026, but posted a net loss after recording a $90.3 million non-cash deferred tax charge tied to earnings retained in Papua New Guinea. The company produced 49,776 gold equivalent ounces, up abou
Via MarketBeat · November 16, 2026
VEON Targets Up to $9 Billion in Revenue by 2030 as Fintech and AI Drive Growthmarketbeat.com
VEON (NASDAQ:VEON) outlined plans to grow revenue by 12% to 15% annually in U.S. dollar terms through 2030, as it expands financial services, entertainment and artificial intelligence offerings on top of its telecommunications networks. At the company’s Capital Markets Day, Chief Executive Officer
Via MarketBeat · November 16, 2026
What PagSeguro Digital (PAGS) Said on Its Q3 Earnings Callmarketbeat.com
PagSeguro Digital (NYSE:PAGS) cut its 2026 gross profit growth forecast after slower-than-expected interest rate reductions in Brazil, even as third-quarter earnings rose on growth in credit and banking and lower funding costs. The company, which operates as PagBank, now expects gross profit to inc
Via MarketBeat · November 16, 2026
One ETF or Several? How to Keep Your Investments as Simple as Possiblefool.ca
Here's how choosing the right mix of ETFs could help you simplify your investments while building long-term wealth.
Via The Motley Fool · November 16, 2026
1 Top Dividend ETF to Buy to Generate Passive Incomefool.ca
Vanguard's VDY pays monthly, with a 0.22% MER and a 3% yield. See what $20,000 could earn, the bank and energy risks, and how this ETF fits in your TFSA.
Via The Motley Fool · November 16, 2026
2 of the Best ETFs to Buy Nowfool.ca
Looking for the best ETFs to buy now? Explore how XEQT offers global stock exposure while ZAG adds Canadian bonds to a long-term portfolio.
Via The Motley Fool · November 16, 2026
2 TSX Giants to Buy for Decades of Growth and Dividendsfool.ca
Royal Bank of Canada (TSX:RY) and another dividend giant worth buying up for decades.
Via The Motley Fool · November 16, 2026
Prediction: Nov. 18 Will Be a Huge Day for AI Power Stocks. Here’s Why.fool.com
Nvidia’s earnings, the first since Jensen Huang’s exit, could show whether AI spending is still climbing.
Via The Motley Fool · November 16, 2026
Aquestive Therapeutics Eyes Needle-Free Allergy Treatment Launch Ahead of 2027 FDA Decisionmarketbeat.com
Aquestive Therapeutics (NASDAQ:AQST) is preparing for a potential U.S. launch of its needle-free treatment for severe allergic reactions, with an FDA decision expected on March 16, 2027, CEO Dan Barber said at the 2026 Jefferies Global Healthcare Conference. The company’s lead product candidate, An
Via MarketBeat · November 16, 2026
PICS Q3 Earnings Call Highlightsmarketbeat.com
PicPay, operated by PICS (NASDAQ:PICS), reported rapid credit growth and higher third-quarter earnings, while outlining an upcoming change to its loan write-off policy that it expects to reduce fourth-quarter net income by approximately BRL 325 million. The company’s credit portfolio reached BRL 35
Via MarketBeat · November 16, 2026
What Infleqtion (INFQ) Said on Its Q3 Earnings Callmarketbeat.com
Infleqtion (NYSE:INFQ) reported third-quarter revenue growth and maintained its full-year sales guidance, while executives pointed to a quantum computing milestone and rising customer commitments as signs of momentum heading into 2027. Revenue rose 25% from a year earlier to $9.1 million, though it
Via MarketBeat · November 16, 2026
XP Q3 Earnings Call Highlightsmarketbeat.com
XP (NASDAQ:XP) reported higher third-quarter revenue and adjusted earnings as growth in its retail and corporate businesses helped offset a challenging environment for capital markets. The company also announced a new share buyback and dividend, while executives outlined expectations for revenue gro
Via MarketBeat · November 16, 2026
What H&R Real Estate Investment Trust (HR.UN) Said on Its Q3 Earnings Callmarketbeat.com
H&R Real Estate Investment Trust (TSE:HR.UN) reported a decline in third-quarter funds from operations and a drop in net asset value after recording substantial property valuation adjustments, while management said its future strategy would be reviewed by a refreshed board following the failure
Via MarketBeat · November 16, 2026
Omeros Q3 Earnings Call Highlightsmarketbeat.com
Omeros (NASDAQ:OMER) reported higher third-quarter sales of its transplant complication treatment YARTEMLEA and a second consecutive quarter of positive operating cash flow, while a non-cash adjustment tied to its convertible notes pushed the company to a net loss. YARTEMLEA generated $35.9 million
Via MarketBeat · November 16, 2026